Marsha Fanucci Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Marsha Fanucci.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Marsha Fanucci. Marsha Fanucci is SVP, Chief Financial Officer in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and Director in IRONWOOD PHARMACEUTICALS INC ($IRWD) and Director in Forma Therapeutics Holdings, Inc., ($FMTX) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Cyclerion Therapeutics, Inc. ($CYCN).
Latest Insider Trading Transactions of Marsha Fanucci
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, CYCN, FMTX, IRWD, MLNM, MNTA, SYRS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jun 24 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Sell | S | 0.00 | 14,026 | 0 | 0 | 14 K to 0 (-100.00 %) |
Jun 24 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Sell | S | 0.00 | 10,240 | 0 | 0 | 10.2 K to 0 (-100.00 %) |
Jun 24 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Sell | S | 0.00 | 9,847 | 0 | 0 | 9.8 K to 0 (-100.00 %) |
Jun 24 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Sell | S | 0.00 | 33,781 | 0 | 0 | 33.8 K to 0 (-100.00 %) |
Jun 24 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Buy | P | 0.00 | 52,532 | 0 | 52,532 | 0 to 52.5 K |
Jun 24 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Sell | S | 0.00 | 14,026 | 0 | 0 | 14 K to 0 (-100.00 %) |
Jun 24 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Sell | S | 0.00 | 10,240 | 0 | 0 | 10.2 K to 0 (-100.00 %) |
Jun 24 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Sell | S | 0.00 | 9,847 | 0 | 0 | 9.8 K to 0 (-100.00 %) |
Jun 24 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Sell | S | 0.00 | 33,781 | 0 | 0 | 33.8 K to 0 (-100.00 %) |
Jun 24 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Buy | P | 0.00 | 52,532 | 0 | 52,532 | 0 to 52.5 K |
Jun 22 2020 | FMTX | Forma Therapeutics ... | Fanucci Marsha | Director | Option Exercise | A | 20.00 | 17,533 | 350,660 | 0 | |
Jun 18 2020 | CYCN | Cyclerion Therapeu ... | Fanucci Marsha | Director | Option Exercise | A | 4.46 | 10,000 | 44,600 | 10,000 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | Fanucci Marsha | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | M | 30.09 | 15,000 | 451,350 | 0 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | M | 9.30 | 15,000 | 139,500 | 0 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | M | 11.33 | 15,000 | 169,950 | 0 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | M | 9.14 | 30,000 | 274,200 | 0 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Sell | S | 100.00 | 75,000 | 7,500,000 | 0 | 75 K to 0 (-100.00 %) |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Buy | M | 30.09 | 15,000 | 451,350 | 75,000 | 60 K to 75 K (+25.00 %) |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Buy | M | 11.33 | 15,000 | 169,950 | 60,000 | 45 K to 60 K (+33.33 %) |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Buy | M | 9.30 | 15,000 | 139,500 | 45,000 | 30 K to 45 K (+50.00 %) |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Buy | M | 9.14 | 30,000 | 274,200 | 30,000 | 0 to 30 K |
Jun 12 2019 | SYRS | Syros Pharmaceutic ... | Fanucci Marsha | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
Jun 04 2019 | CYCN | Cyclerion Therapeu ... | Fanucci Marsha | Director | Option Exercise | A | 13.95 | 10,000 | 139,500 | 10,000 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Fanucci Marsha | Director | Grant | A | 0.00 | 3,279 | 0 | 16,950 | 13.7 K to 17 K (+23.99 %) |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Fanucci Marsha | Director | Grant | A | 0.00 | 13,671 | 0 | 13,671 | 0 to 13.7 K |
Jan 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Fanucci Marsha | Director | Buy | J | 0.00 | 44,863 | 0 | 136,719 | 91.9 K to 136.7 K (+48.84 %) |
Jan 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Fanucci Marsha | Director | Sell | J | 0.00 | 44,863 | 0 | 0 | 44.9 K to 0 (-100.00 %) |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 15 2018 | SYRS | Syros Pharmaceutic ... | Fanucci Marsha | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
Jun 04 2018 | IRWD | IRONWOOD PHARMACEU ... | Fanucci Marsha | Director | Grant | A | 0.00 | 16,223 | 0 | 91,856 | 75.6 K to 91.9 K (+21.45 %) |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | Fanucci Marsha | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 02 2017 | IRWD | IRONWOOD PHARMACEU ... | Fanucci Marsha | Director | Grant | A | 0.00 | 15,625 | 0 | 75,633 | 60 K to 75.6 K (+26.04 %) |
Sep 19 2016 | SYRS | Syros Pharmaceutic ... | Fanucci Marsha | Director | Option Exercise | A | 12.59 | 22,000 | 276,980 | 22,000 | |
Jun 27 2016 | MNTA | MOMENTA PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 10.97 | 11,000 | 120,670 | 11,000 | |
Jun 27 2016 | MNTA | MOMENTA PHARMACEUT ... | Fanucci Marsha | Director | Grant | A | 0.00 | 5,500 | 0 | 14,500 | 9 K to 14.5 K (+61.11 %) |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Jun 03 2016 | IRWD | IRONWOOD PHARMACEU ... | Fanucci Marsha | Director | Grant | A | 0.00 | 23,674 | 0 | 60,008 | 36.3 K to 60 K (+65.16 %) |
Jun 11 2015 | MNTA | MOMENTA PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 22.18 | 17,750 | 393,695 | 176,350 | |
Jun 05 2015 | IRWD | IRONWOOD PHARMACEU ... | Fanucci Marsha | Director | Grant | A | 0.00 | 16,556 | 0 | 36,334 | 19.8 K to 36.3 K (+83.71 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
Mar 20 2015 | IRWD | IRONWOOD PHARMACEU ... | Fanucci Marsha | Director | Sell | S | 15.68 | 31,339 | 491,396 | 19,778 | 51.1 K to 19.8 K (-61.31 %) |
Feb 27 2015 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Sell | S | 107.36 | 700 | 75,150 | 0 | 700 to 0 (-100.00 %) |
Feb 27 2015 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Sell | S | 106.72 | 3,025 | 322,818 | 700 | 3.7 K to 700 (-81.21 %) |
Feb 27 2015 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Sell | S | 105.66 | 2,621 | 276,925 | 3,725 | 6.3 K to 3.7 K (-41.30 %) |
Feb 27 2015 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Sell | S | 104.83 | 3,654 | 383,059 | 6,346 | 10 K to 6.3 K (-36.54 %) |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 13.90 | 68,395 | 950,691 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 10.84 | 45,000 | 487,800 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 8.41 | 212,500 | 1,787,125 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 13.67 | 25,000 | 341,750 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 13.36 | 125,000 | 1,670,000 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 12.09 | 37,500 | 453,375 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 11.89 | 25,000 | 297,250 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 11.15 | 25,000 | 278,750 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 17.77 | 37,500 | 666,375 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 18.65 | 7,812 | 145,694 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 15.83 | 7,812 | 123,664 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 15.92 | 7,813 | 124,383 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 15.45 | 7,118 | 109,973 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 14.68 | 19,272 | 282,913 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 13.91 | 7,118 | 99,011 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 12.57 | 7,119 | 89,486 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 6.88 | 19,271 | 132,584 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 9.35 | 2,987 | 27,928 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 8.27 | 2,988 | 24,711 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 7.99 | 2,988 | 23,874 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 18.42 | 6,855 | 126,269 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 22.04 | 13,164 | 290,135 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 19.49 | 13,164 | 256,566 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | D | 16.13 | 6,019 | 97,086 | 0 | |
May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | D | 25.00 | 109,514 | 2,737,850 | 0 | 109.5 K to 0 (-100.00 %) |
May 12 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | U | 25.00 | 3,270 | 81,750 | 109,514 | 112.8 K to 109.5 K (-2.90 %) |
Mar 11 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | S | 12.82 | 4,429 | 56,780 | 112,784 | 117.2 K to 112.8 K (-3.78 %) |
Mar 11 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | S | 13.34 | 5,989 | 79,891 | 117,213 | 123.2 K to 117.2 K (-4.86 %) |
Mar 04 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | S | 13.68 | 5,480 | 74,940 | 123,202 | 128.7 K to 123.2 K (-4.26 %) |
Feb 19 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | A | 13.90 | 68,395 | 950,691 | 68,395 | |
Feb 19 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Grant | A | 0.00 | 30,400 | 0 | 128,682 | 98.3 K to 128.7 K (+30.93 %) |
Feb 19 2008 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Grant | A | 0.00 | 22,800 | 0 | 98,282 | 75.5 K to 98.3 K (+30.21 %) |
Sep 19 2007 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | S | 10.67 | 7,436 | 79,342 | 75,482 | 82.9 K to 75.5 K (-8.97 %) |
Sep 19 2007 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | S | 10.58 | 10,064 | 106,477 | 82,918 | 93 K to 82.9 K (-10.82 %) |
Mar 12 2007 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | S | 10.64 | 4,245 | 45,167 | 92,982 | 97.2 K to 93 K (-4.37 %) |
Mar 12 2007 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | S | 10.41 | 6,173 | 64,261 | 97,227 | 103.4 K to 97.2 K (-5.97 %) |
Mar 01 2007 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | A | 10.84 | 45,000 | 487,800 | 45,000 | |
Mar 01 2007 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Grant | A | 0.00 | 20,000 | 0 | 103,400 | 83.4 K to 103.4 K (+23.98 %) |
Mar 01 2007 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Grant | A | 0.00 | 15,000 | 0 | 83,400 | 68.4 K to 83.4 K (+21.93 %) |
Mar 01 2007 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Grant | A | 0.00 | 9,230 | 0 | 68,400 | 59.2 K to 68.4 K (+15.60 %) |
Feb 07 2007 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | S | 11.17 | 7,497 | 83,741 | 59,170 | 66.7 K to 59.2 K (-11.25 %) |
Sep 19 2006 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Sell | S | 10.95 | 10,003 | 109,533 | 66,667 | 76.7 K to 66.7 K (-13.05 %) |
Mar 08 2006 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Grant | A | 0.00 | 41,670 | 0 | 76,670 | 35 K to 76.7 K (+119.06 %) |
Sep 19 2005 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Grant | A | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
Mar 07 2005 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | A | 8.41 | 212,500 | 1,787,125 | 212,500 | |
Oct 01 2004 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | A | 13.67 | 25,000 | 341,750 | 25,000 | |
Sep 27 2004 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | A | 13.36 | 125,000 | 1,670,000 | 125,000 | |
Sep 02 2004 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | A | 12.09 | 37,500 | 453,375 | 37,500 | |
Sep 02 2004 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | A | 11.89 | 25,000 | 297,250 | 25,000 | |
Sep 02 2004 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | A | 12.09 | 37,500 | 453,375 | 37,500 | |
Sep 02 2004 | MLNM | MILLENNIUM PHARMAC ... | Fanucci Marsha | SVP, Chief Financia ... | Option Exercise | A | 11.89 | 25,000 | 297,250 | 25,000 |
Page: 1